Results 81 to 90 of about 257,551 (158)

[Expression of Concern] Insulin-like growth factor-1 receptor knockdown enhances radiosensitivity via the HIF-1α pathway and attenuates ATM/H2AX/53BP1 DNA repair activation in human lung squamous carcinoma cells. [PDF]

Oncol Lett
Liu X, Chen H, Xu X, Ye M, Cao H, Xu L, Hou Y, Tang J, Zhou D, Bai Y, Ma X.   +10 more
europepmc   +1 more source

Molecular basis for the role of disulfide-linked αCTs in the activation of insulin-like growth factor 1 receptor and insulin receptor. [PDF]

Elife, 2022
Li J, Wu J, Hall C, Bai XC, Choi E.
europepmc   +1 more source

N-acetylglucosaminyltransferase V attenuates myocardial infarction by mediating the insulin-like growth factor 1 receptor signaling pathway. [PDF]

J Transl Int Med
Chang T, Jin Y, Fan C, Wang H, Jin L, Shi Y, Li H, Wang J, Xu M.   +8 more
europepmc   +1 more source

Costs and Causes of Oncology Drug Attrition With the Example of Insulin-Like Growth Factor-1 Receptor Inhibitors.

JAMA Netw Open, 2023
Jentzsch V, Osipenko L, Scannell JW, Hickman JA.   +3 more
europepmc   +1 more source

Insulin-Like Growth Factor 1 Receptor Deficiency Alleviates Angiotensin II-Induced Cardiac Fibrosis Through the Protein Kinase B/Extracellular Signal-Regulated Kinase/Nuclear Factor-κB Pathway. [PDF]

J Am Heart Assoc, 2023
Zhu J, Li Q, Sun Y, Zhang S, Pan R, Xie Y, Chen J, Shi L, Chen Y, Sun Z, Zhang L.   +10 more
europepmc   +1 more source

Fine-Tuning Cardiac Insulin-Like Growth Factor 1 Receptor Signaling to Promote Health and Longevity. [PDF]

Circulation, 2022
Abdellatif M, Trummer-Herbst V, Heberle AM, Humnig A, Pendl T, Durand S, Cerrato G, Hofer SJ, Islam M, Voglhuber J, Ramos Pittol JM, Kepp O, Hoefler G, Schmidt A, Rainer PP, Scherr D, von Lewinski D, Bisping E, McMullen JR, Diwan A, Eisenberg T, Madeo F, Thedieck K, Kroemer G, Sedej S.   +24 more
europepmc   +1 more source

Correction: MicroRNA-497 targets insulin-like growth factor 1 receptor and has a tumour suppressive role in human colorectal cancer. [PDF]

Oncogene
Guo ST, Jiang CC, Wang GP, Li YP, Wang CY, Guo XY, Yang RH, Feng Y, Wang FH, Tseng H-, Thorne RF, Jin L, Zhang XD.   +12 more
europepmc   +1 more source

Brain Delivery of IGF1R5, a Single-Domain Antibody Targeting Insulin-like Growth Factor-1 Receptor. [PDF]

Pharmaceutics, 2022
Yogi A, Hussack G, van Faassen H, Haqqani AS, Delaney CE, Brunette E, Sandhu JK, Hewitt M, Sulea T, Kemmerich K, Stanimirovic DB.   +10 more
europepmc   +1 more source

Targeting the insulin-like growth factor-1 receptor to overcome imatinib resistance in chronic myeloid leukemia. [PDF]

Discov Oncol
Okabe S, Arai Y, Gotoh A.
europepmc   +1 more source

Effects of targeted-edited oncogenic insulin-like growth factor-1 receptor with specific-sgRNA on biological behaviors of HepG2 cells. [PDF]

World J Clin Cases, 2022
Yao M, Cai Y, Wu ZJ, Zhou P, Sai WL, Wang DF, Wang L, Yao DF.   +7 more
europepmc   +1 more source